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the 12th annual Scientific Sessions of the American Society
f Nuclear Cardiology (ASNC) (chaired by Dr. Brian
bbott) were held in San Diego, California, from Septem-
er 6 through 9, 2007. The meeting, entitled “Cardiac
maging: Imagine the Future,” attracted over 1,700 attend-
es. The scientific sessions were structured along specifically
esigned tracks, including the technical, core, and advanced
racks focusing on nuclear cardiac imaging and a dedicated
omputed tomography (CT) track, addressing the growing
ole of CT in noninvasive cardiac imaging and its integra-
ion with nuclear techniques in hybrid cardiac imaging.
hese tracks were complemented by the plenary sessions,
hich included keynote speakers addressing the role of
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niversity Feinberg School of Medicine, Chicago, Illinois; **New York University
chool of Medicine, New York, New York; ††Mission Internal Medical Group,
ission Viejo, California; ‡‡The Mid America Heart Institute, Kansas City,
issouri; and the §§Leiden University Medical Center, Leiden, the Netherlands. Dr.
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Manuscript received October 15, 2007; accepted October 24, 2007.uclear cardiology in the healthcare system. Original re-
earch was presented in abstract presentations and a Young
nvestigator Award competition.
lenary Sessions
r. Robert Bonow gave the sixth annual Mario Verani
emorial Lecture, which is presented each year at the
SNC annual meeting by a prominent nuclear cardiologist,
n memory of Dr. Mario Verani (1943 to 2001), a pioneer
n nuclear cardiology and founder and past president of the
SNC. Dr. Bonow pointed out the gains that have been
ade in the fight against cardiovascular disease in the U.S.,
ith deaths due to coronary artery disease (CAD) declining
ince the 1970s. With this backdrop, he posed the question:
hat role does imaging play in improved outcomes? There
as been a tremendous increase, on the basis of data from
he Centers for Medicare and Medicaid Services and other
ources, in the number of stress tests performed over the
ast 10 years, owing in large part to increases in myocardial
erfusion imaging (MPI). With this increase comes an
ncrease in cost, and Dr. Bonow asked whether this added
ost provides added value. Cardiac imaging, mostly nuclear
maging and echocardiography at this point in time, has
een shown to be useful for the diagnosis of CAD. In
ddition, there is a wealth of data, particularly regarding
uclear imaging, supporting the prognostic value of such
ests. A normal study portends an excellent prognosis,
hereas the prognosis becomes progressively worse with
ncreasing degrees of abnormality of these tests. He noted,
owever, that all of the prognostic studies were retrospec-
ive, nonrandomized trials. Only one prospective study, the
ND (Economics of Noninvasive Diagnosis) study, dem-
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December 11, 2007:2336–43 Highlights of the 2007 ASNC Scientific Sessionsnstrated an economic benefit to a strategy of performing
PI to determine who needed cardiac catheterization
ersus a strategy of going directly to angiography. This
conomic benefit was noted despite similar outcomes in the
roups. Dr. Bonow also discussed the recent data regarding
he ability of cardiac CT to diagnose CAD and provide
rognostic information. Several studies have shown the
elationship between the coronary artery calcium (CAC)
core and mortality or cardiac events. On the basis of the
vailable data, cardiac CT might be a useful tool to help
isk-stratify patients, particularly those at intermediate risk
or events on the basis of traditional risk factors. However,
here are still many unresolved issues regarding the practice
f cardiovascular imaging, including which patients should
e studied, who should interpret the studies, who will pay
or the studies, and how quality of the testing and the
esultant images will be determined and maintained. Dr.
onow concluded that cardiovascular imaging has become a
ornerstone in the diagnosis and management of patients
ith heart disease and has transformed and will continue to
ransform cardiovascular care. The exciting new imaging
odalities create a unique opportunity to improve diagnos-
ic and clinical management strategies. However, they also
ring challenges in patient selection, clinical training, inte-
ration with established imaging methods, resource use, and
ost effectiveness.
The keynote address in the second plenary session was
iven by Dr. Raymond Gibbons, past president of the
merican Heart Association. In his talk, Dr. Gibbons
autioned the audience that we are in the midst of a health
are crisis. Health costs have increased to a greater degree
han inflation over the past decade. The increase in cardiac
maging procedures has caused insurers to focus on control-
ing imaging through methods such as requiring pre-
pproval of MPI as a way to reduce costs. Furthermore, part
f the Deficit Reduction Act of 2005 included a reduction
n payments for imaging. It is important to respond to these
hallenges in a meaningful and responsible manner. Dr.
ibbons noted that there are tremendous regional variations
n how often imaging stress testing is used. Furthermore, he
iscussed the American College of Cardiology/ASNC ap-
ropriateness criteria for MPI and how following these
uidelines can reduce the number of inappropriate tests. Dr.
ibbons concluded that it is essential to continue to
enerate rigorous scientific evidence that emphasizes qual-
ty, efficiency, and outcomes and that physicians must begin
o regulate testing and eliminate inappropriate testing.
he role of cardiac imaging in high-risk and specialized
opulations. The role of MPI and CT in patients with
iabetes mellitus was discussed by Dr. Frans Wackers. He
ointed out the well-known fact that diabetes is considered
“CAD equivalent” because of the high risk for cardiac
vents in diabetic patients, with an increased mortality and
orse outcomes after myocardial infarction. These factors
ave led Dr. Wackers and others to wonder whether
symptomatic diabetic patients should be screened for cAD. He noted that the prevalence of abnormal stress
ingle-photon emission computed tomography (SPECT)
tudies in diabetic patients depends on the population being
tudied, with prevalence as high as 58% or as low as 7%. The
IAD (Detection of Ischemia in Asymptomatic Diabetics)
tudy demonstrated that 22% had abnormal MPI, with 6%
aving markedly abnormal studies. Pre-screening with car-
iac CT (using CAC) might enrich the population that
ould benefit from MPI, because patients with high CAC
cores have a high likelihood of abnormal MPI.
Dr. Kim Williams reviewed the role of cardiac imaging in
atients with renal failure, a group that is at increased risk
or cardiac events, with 54% of the deaths due to cardio-
ascular causes. There are many possible mechanisms for
his increased risk, including accelerated atherosclerosis,
ncreased vascular calcification, left ventricular (LV) hyper-
rophy and dysfunction, anemia, hypertension, elevated
omocysteine concentrations, and increased vasoconstric-
ion. Cardiac CT studies have shown increased coronary
alcification in end-stage renal disease, and higher CAC
cores are associated with worse outcomes. Also, SPECT
PI could effectively risk-stratify patients undergoing renal
ransplantation, but even those with normal SPECT results
ad a relatively high event rate of 3%, suggesting that other
echanisms besides ischemia determine the increased mor-
ality in this patient group.
Dr. Leslee Shaw discussed the often-debated topic of the
ole of noninvasive imaging in asymptomatic high-risk
atients. She described the high-risk groups, including
igh-risk elderly patients (in whom 20% might have an
nkle-brachial index of 0.9), those who are functionally
mpaired, patients who smoke, those with metabolic syn-
rome, high-risk women, and obese patients (who would
eem to need other risk factors to be considered candidates
or testing).
ore Curriculum: Update in Nuclear Cardiology
he primary focus of the core curriculum was to present
ractical information relevant to the everyday practice of
uclear cardiology. In addition to presenting many funda-
ental concepts important to nuclear cardiology, the ses-
ions emphasized new developments in nuclear and CT
maging.
merging applications of SPECT perfusion imaging and
ardiac CT. Many of the Core Curriculum sessions fo-
used on emerging applications and recent developments in
PECT MPI. Dr. James Udelson highlighted the impor-
ant role of MPI in several important patient populations. In
atients with heart failure and systolic LV dysfunction, MPI
ight be used to identify patients who have significant
AD who might benefit from additional evaluation or
reatment. In patients with known CAD, emerging evi-
ence supports the role of MPI to determine which patients
ill likely benefit from aggressive interventions, such asoronary revascularization and/or medical therapy. In par-
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Highlights of the 2007 ASNC Scientific Sessions December 11, 2007:2336–43icular, the quantitative aspect of MPI might be important
n this regard, because there is a threshold of ischemia on
PI, which might indicate patients who will have thera-
eutic benefit. Dr. Christopher Hansen discussed the im-
ortant role of MPI in secondary prevention, highlighting
he strong relationship between perfusion abnormalities and
ardiac event rate, and recent evidence from the INSPIRE
Adenosine Sestamibi Post Infarction Evaluation) trial,
hich supports a role for adenosine MPI in the assessment
f risk soon after myocardial infarction. In this prospective,
ulticenter trial, MPI results significantly improved predic-
ion of subsequent death or myocardial infarction beyond
he information provided by clinical (i.e., Thrombolysis In
yocardial Infarction risk score) and LV ejection fraction
ariables.
The complementary roles of cardiac CT and MPI were
omprehensively reviewed by Dr. Leslee Shaw. Whereas
here are data on the prognostic role for both coronary
alcium measurement and MPI in patients at risk for
oronary disease, Dr. Shaw highlighted the importance of
istinguishing between a measurement of atherosclerotic
urden and a measurement of ischemic burden. In low- to
ntermediate-risk patients, emerging evidence supports ini-
ial assessment of atherosclerotic burden by CAC scoring
ollowed by stress MPI to assess ischemic burden in patients
ith abnormal CAC scores. Furthermore, evidence contin-
es to support the important role of MPI as the initial test
or risk stratification of patients at high risk for CAD. Trials
re currently underway to assess the potential utility of
ybrid SPECT/CT or positron emission tomography
PET)/CT systems to assess both atherosclerotic and isch-
mic burden in patients at risk for coronary disease.
ew developments in nuclear imaging. The ASNC Core
urriculum also highlighted a number of new developments
n cardiac SPECT and PET, which will expand the poten-
ial applications of nuclear imaging. Dr. Vasken Dilsizian
eviewed the current status of metabolic imaging with iodine-
23 -methyl-iodophenyl-pentadecanoic acid (BMIPP) and
-18 fluorodeoxyglucose and discussed the use of these tracers
s markers of recent ischemic events (ischemic memory).
esults from a recent phase-2 trial of BMIPP show that this
gent might detect ischemia up to 30 h after an ischemic
pisode, long after the perfusion defect has normalized. A
hase-2 trial is currently underway, investigating the poten-
ial role for BMIPP in the evaluation of patients presenting
ith chest pain. The current status of rest/stress PET MPI
as reviewed by Dr. Terrence Ruddy. Recent evidence
ndicates that PET MPI has a very high sensitivity to detect
ingle- and multivessel CAD and that the overall accuracy
emains equally high in obese patients and women.
Quantification of LV function remains a focus of nuclear
ardiology techniques, and Dr. Guido Germano described a
umber of important new methods that might derive even
ore detailed information from SPECT MPI studies. For
he assessment of LV function, diastolic filling might be
ssessed by analysis of ventricular volume curves on gated tPECT. Phase analysis of regional ventricular function
ight be an important method to assess ventricular syn-
hrony and could play an important role in identifying
atients who would benefit from cardiac resynchronization
herapy. In addition to assessment of LV function, it is now
ossible to assess right ventricular ejection fraction with
ated SPECT. For assessment of myocardial perfusion, new
evelopments in acquisition and processing might lead to
ncreased resolution by “motion freezing” the heart in
iastole and also allow accurate quantification of changes in
erfusion on the basis of serial imaging.
nsuring quality of imaging. The theme of ensuring
uality in imaging was emphasized in the entire ASNC
urriculum. Dr. Thomas Holly reviewed the rationale for
sing automated perfusion scores as an aid in the evaluation
f MPI studies, emphasizing the potential role these pro-
rams can have in ensuring accurate interpretation of
tudies. Dr. Edward Ficaro discussed the importance of
uality control in SPECT/CT systems, which is particularly
mportant with the growing use of CT-based attenuation
orrection algorithms. Proper registration of CT and
PECT images is the single most important issue to ensure
uality studies. The importance of reviewing all imaging
ata, including the attenuation maps and fused images, was
mphasized.
dvanced Track: Recent Progress
n Tracers and Imaging Technology
he advanced track is traditionally dedicated to novel,
ecently introduced topics related to tracers and imaging
ethodology. Both basic science concepts of cardiac imag-
ng as well as clinical aspects are covered. A first session was
edicated to the role of imaging in heart failure, which is a
opic of growing interest given the increasing prevalence and
ncidence of heart failure. Dr. Robert Bonow highlighted
rogress in the treatment of congestive heart failure. The
ncreasing diversity of therapeutic options results in an
ncreasing demand for imaging techniques to guide thera-
eutic decision-making. Dr. Kevin Allman elaborated on
he prognostic value of nuclear imaging in heart failure. For
xample, viability imaging can be used to guide the clinician
oward revascularization or medical therapy of ischemic LV
ysfunction, on the basis of presence and extent of viable but
eopardized myocardium. The role of innervation imaging
as subsequently emphasized by Dr. Mark Travin. Neuro-
al dysfunction can be identified in the failing heart and has
mplications for disease progression, arrhythmogenesis, and
utcome. Iodine-123 metaiodobenzylguanidine is a tracer
hat is currently being evaluated in multicenter clinical trials
nd might soon become available for stratification of heart
ailure patients on the basis of the degree of cardiac
enervation. Dr. Leo Hofstra introduced novel techniques
o predict LV remodeling with molecular imaging radio-
racers. A promising approach currently being tested exper-
i
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December 11, 2007:2336–43 Highlights of the 2007 ASNC Scientific Sessionsmentally is the use of integrin ligands to identify the
everity of post-ischemic myocardial damage.
A second session was dedicated to novel instrumentation.
r. Ernest Garcia summarized trends in SPECT and PET
nstrumentation toward more sensitive higher resolution
ystems. Dr. Daniel Berman then provided an overview of
he new generation of dedicated, fast cardiac SPECT
ystems, which will allow for a dramatic reduction in
cquisition time and hold the promise of providing dy-
amic, quantitative SPECT imaging in the future. Motion
orrection and CT-based attenuation correction are other
echnical advances for SPECT, which will contribute to
mproved accuracy, as highlighted by Dr. James Case.
ecent developments in software methodology have now
rovided tools for robust and reproducible fusion of nuclear
nd CT angiographic images, as shown by Dr. Philipp
aufmann.
New trends in molecular imaging, which is an area of
ctive investigation on the basic science and preclinical
evels, were the topic of another advanced track session. Dr.
yung Chun discussed the nuclear imaging techniques that
an be used for tracking of stem cells and explained how
hese techniques can facilitate and improve understanding
f stem cell therapy as a novel approach to restore damaged
yocardium. Dr. Frank Bengel demonstrated how multiple
racers of the sympathetic nervous system can be combined
o obtain deeper insights into the role of autonomic inner-
ation for cardiac disease. Dr. Mehran Sadeghi provided an
verview of novel tracers that allow for biologic character-
zation of atherosclerotic lesions. The session was concluded
y Dr. Leo Hofstra, who discussed the potential of
nnexin-V as a marker of cell death in cardiomyopathy,
schemia, and plaque characterization.
Another session was fully dedicated to the role of nuclear
maging for characterizing the process of atherosclerosis.
r. Leo Hofstra provided an overview on the pathophysi-
logy of the vulnerable plaque and how lesions without
ignificant luminal narrowing can contribute to life-
hreatening vascular occlusion. Dr. Heinrich Schelbert sub-
equently outlined how PET flow imaging can be used to
dentify coronary endothelial dysfunction as a diffuse pro-
ess, which is considered an early marker of atherosclerosis
nd a facilitator of plaque progression. Dr. Mehran Sadeghi
hen summarized tracers that have been introduced to
dentify biologic features of plaque vulnerability, and Dr.
oanne Schuijf concluded the session by pointing out the
otential of cardiac CT to identify morphologic compo-
ents of plaque composition.
In addition to new tracers and technical advances, phar-
acologic stressors and the definition of their clinical role
ave evolved in recent years. A session was devoted to the
atest developments in pharmacologic testing, and Dr.
avid Glover started the session by explaining the physiol-
gy and pharmacology of the adenosine receptor system as
primary target of vasodilator stress testing. Dr. Robert
endel presented initial clinical results of adenosine A2a teceptor agonists as novel, promising stress agents that are
asy to administer and have fewer side-effects than adenosine.
The final session in the advanced track focused on the
ole of nuclear imaging for monitoring cardiac therapy, a
opic that has generated increasing interest, owing to the
ontinuously growing number of therapeutic options in
reating cardiovascular disease. Dr. Tracy Faber explained
ow quantitative analysis of nuclear cardiac studies is helpful
n improving the reproducibility and comparability of serial
maging before and after therapy. Dr. George Beller pro-
ided an update on the high value of MPI to evaluate
nterventions. Dr. Paolo Raggi illustrated how CT can be
sed for monitoring atherosclerotic plaque progression, and
r. Juhani Knuuti showed how PET, owing to its potential
or absolute quantification, is a very powerful tool in
dentifying the efficacy of therapeutic interventions.
The variety of topics covered in the advanced track clearly
ighlighted that the field of nuclear cardiology is moving
orward. Novel tracers and the implementation of molecular
maging techniques help in broadening the application of
maging in cardiovascular disease. Novel camera and stress-
esting methodologies will facilitate clinical throughput and
atient comfort. In addition, the entire field has focused on
oving toward an individual characterization of disease-
elated risk, to guide effective therapeutic decision-making.
echnical Track: Innovations
n Clinical Nuclear Cardiology
evices for faster acquisition. Several presentations em-
hasized the need to implement acquisition protocols that
horten the total imaging time to increase patient through-
ut and comfort as well as to improve image quality. These
rotocols might also be used to reduce radiation dose.
everal manufacturers now have software solutions in the
orm of iterative reconstruction methods that have been
mplemented to account more properly for the geometry of
he system for resolution recovery and to perform noise
eduction to yield images of comparable conventional qual-
ty in one-half the conventional acquisition time. These
ethods are often called wide beam reconstruction (WBR),
lthough each manufacturer uses their own proprietary
ame for the approach. Clinical trials using this approach
re beginning to show that electrocardiography (ECG)-
ated MPI studies acquired in one-half the conventional
ime and reconstructed with WBR yield perfusion and
unction information comparable to that acquired and
econstructed with filtered back projection in the same
atient. Because of the higher contrast of WBR images
ompared with filtered back projection images, the WBR
mages are often rated as higher quality. This improved
ontrast results in larger LV volumes when compared with
onventional protocols.
Hardware solutions to the faster acquisition challenge
ere also widely reported. These hardware solutions takehe form of totally new camera/detector designs to perform
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Highlights of the 2007 ASNC Scientific Sessions December 11, 2007:2336–43uch faster SPECT imaging, in the range of 3 to 10 times
he conventional sensitivity with no loss in resolution. The
esigns vary from as simple as adding a third SPECT
etector to as unconventional as having 10 solid-state
admium zinc telluride detectors constantly scanning the
eart region. Other designs used a stationary curved detec-
or system where only the collimator slat system moves to
can the heart; and another design used 2 conventional
PECT detectors mounted with multi-pinhole collimators
ointed at the heart region. One advantage of this multi-
inhole approach is that there are no moving parts.
The collective presentations on SPECT technology
learly indicate that we are seeing both a rebirth of this
echnology as well as a commitment from manufacturers
nd researchers alike to move this technology forward.
everal presentations emphasized the need to continue to
ptimize quality in patient care by performing quality
ontrol of acquisition and processing protocols of conven-
ional SPECT imaging and to begin to develop and
mplement the quality control procedures for the new
evices.
T Track: Complementary Imaging Modality
he ASNC 2007 Scientific Sessions included a track
pecifically for cardiovascular CT. This track included
resentations on cardiac CT research but also state-of-the-
rt lectures on computed tomographic angiography (CTA).
he CT track was introduced by a session on the technical
spects of cardiac CT and included an overview by Dr.
ames Case that provided an important background on the
hysics and instrumentation required for state-of-the art
ardiac CT. Building upon this basis, the importance of
echnical and patient factors affecting study quality—
ncluding issues concerning gating and dose modulation,
eart rate, and contrast delivery and timing of image acquisi-
ion—were emphasized in the following presentations.
Dr. John Mahmarian provided evidence demonstrating
he incremental value CT can provide to SPECT imaging.
pecifically, CT CAC scoring can provide important infor-
ation concerning the burden of coronary calcifications and
elp direct aspirin and statin therapy in patients with no
vidence of perfusion defects on SPECT studies. Further-
ore, CAC scoring can aid in management decisions in
atients with equivocal SPECT findings. With the intro-
uction of hybrid SPECT/CT imaging systems, the iden-
ification of significant coronary artery stenoses increases
ramatically. The use of hybrid systems also extends to PET
maging, in which a growing number of PET cameras are
quipped with multidetector CT for attenuation correction.
owever, these PET/CT systems can also provide hybrid
maging modalities that can provide anatomic and physio-
ogic information. Dr. Juhani Knuuti presented evidence
emonstrating that the ability to detect and localize func-
ionally significant coronary artery lesions is improved when
ultidetector CT is combined with PET. rImprovements in cardiac CT, driven in large part by
echnical advances in multidetector CT, including improve-
ents in both spatial and temporal resolution, have im-
roved the diagnostic performance of CTA. These im-
rovements have led to the application of multidetector CT
o the evaluation of more challenging patient populations,
ncluding patients with in-stent restenosis, bypass grafts,
nd calcified vessels. Dr. Albert Lardo reviewed the rapid
evelopments in the area of cardiac CT for assessment of
iability. Proof-of-concept studies have been performed in
nimals and humans for the assessment of myocardial
iability through the determination of late hyper-
nhancement. The mechanism responsible for hyper-
nhancement 5 min after the injection of X-ray contrast in
atients with myocardial infarction is thought to be related
o disruption of cell membranes in nonviable myocytes
llowing iodine to penetrate the cell.
Physicians interpreting cardiac CT angiographic studies
ave also noticed for some time that the LV myocardium
ubtended by a high-grade coronary occlusion is sometimes
ypo-enhanced on the CT images obtained immediately
fter the initial (i.e., first pass) injection of contrast. Con-
eivably, myocardial perfusion by CTA can be measured at
est and then after coronary vasodilator stress with an agent
uch as adenosine and then measured again during the
yperemic state in order to assess the functional significance
f the coronary lesions. Studies presented by Dr. Richard
eorge suggest that quantification of myocardial washout
inetics for iodinated contrast on multidetector CT studies
ight be able to detect ischemia. These studies so far show
he feasibility of this diagnostic approach. If this line of
nvestigation proves successful, a single CT angiographic
xamination could provide a combination of CAC scoring,
oronary angiographic anatomy, LV function, regional
yocardial perfusion, and myocardial viability in a test
asting 15 min and a radiation dosage of only 12 mSv.
riginal Research: Abstract Contributions
total of 83 abstracts were selected from a group of
ompetitive submissions after peer review. All selected
bstracts were presented in 1 of 5 moderated poster sessions
nd published in the July/August issue of the Journal of
uclear Cardiology. The following is a brief synopsis of these
bstracts.
ew developments in instrumentation. Advances in in-
trumentation and image acquisition were highlighted in a
ariety of abstracts. A comparison of dynamic-SPECT, a
ovel technology for high-speed MPI, with standard image
cquisition showed increased count sensitivity and resolu-
ion with acquisition times of only 2 to 4 min (1). Scan time
as also reduced in a WBR study, demonstrating no
ifferences in quantitative indexes of LV function, thicken-
ng, and volumes (2), and a phantom study of iterative
econstruction combined with CT-based attenuation cor-
ection and scatter correction showed good correlation with
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tudies of attenuation correction demonstrated that the
ttenuation maps obtained from gadolinium-153 transmis-
ion scans are not adversely affected by “half-time” acquisi-
ion protocols (4,5). A study of hybrid imaging with a
ET/CT system in patients with chest pain recruited from
mergency department patients found that the absence of
AC was predictive of a normal adenosine stress
ubidium-82 scan, suggesting that stepwise imaging with
T for CAC performed first might reduce overall radiation
xposure (6). Kajander et al. (7) described a novel approach
o reduce radiation exposure by 60% with prospective
CG-gating of cardiac CT on a hybrid PET/CT system.
wo reports demonstrated the importance of attenuation
orrection. In the first study, a hybrid SPECT/CT system
ith attenuation correction improved diagnostic accuracy
or detecting CAD as compared with noncorrected SPECT
8). In the second study, analysis of SPECT/CT studies
ound that respiratory motion and misregistration of the
erfusion and CT data sets were significant contributors to
alse positive findings (9).
pecial populations. Several abstracts examined the appli-
ation of nuclear cardiac imaging to patients with unique
haracteristics. Patients with advanced chronic kidney dis-
ase (glomerular filtration rate 60 ml/min/1.73 m2) were
oted to have worse stress SPECT perfusion abnormalities
han normal individuals or patients with mild to moderate
enal dysfunction (10). In patients referred for evaluation of
yncope, those with abnormal MPI findings were more
ikely to have known CAD or multiple risk factors (11). Of
77 patients referred for stress MPI with ECG evidence of
V hypertrophy, 60 (34%) died over a 5.5-year follow-up
eriod; an abnormal stress technetium-99m tetrofosmin
PECT study was an independent predictor of mortality
12). Two studies focused on SPECT imaging in transplant
ecipients. Parodi et al. (13) found that SPECT imaging
esults were predictive of long-term prognosis after heart
ransplantation, whereas a presentation by Khan et al. (14)
emonstrated that a normal pharmacologic stress MPI was
ssociated with a very low incidence of adverse cardiac
vents in patients undergoing visceral organ transplants.
inally, one study reported on patients with diabetes type 2
ho underwent MPI with vasodilator stress and exhibited a
lunted heart rate response, suggesting the possibility of
ympathetic denervation (15).
T. The issue of the diagnostic accuracy of coronary CTA
ontinues to be the subject of numerous studies. Chow et al.
16) presented a normalcy rate of 94.5% for CTA in a
opulation with a pre-test probability of CAD 5%,
mphasizing the value of CT to rule out CAD. In addition,
n increasing number of abstracts focused on risk stratifi-
ation with cardiac CT. Two abstracts compared CTA with
he Framingham risk score and reported that total plaque
urden on CTA correlated weakly with the Framingham
isk score (17) and that the risk score was unable to predict
he severity of CAD on CTA (18), suggesting that CT eight have incremental value over the Framingham risk
core. Computed tomographic angiography also identified
ore patients who require aggressive medical therapy than
ould be predicted by Adult Treatment Panel-III guide-
ines or identified by MPI (19). Patients with a higher total
holesterol/high-density lipoprotein cholesterol ratio had a
igher prevalence of proximal and significant CAD on
TA (20). Another CT study in more than 700 patients
emonstrated that low-density plaques were independently
redictive of the occurrence of an acute ischemic episode
ver a 3-year follow-up period (21).
Another topic of interest is the radiation dosage associ-
ted with cardiac diagnostic testing, in particular cardiac
T. One study of the clinical experience with radiation
paring algorithms in coronary CTA revealed that by
oncerted effort the radiation dosage was dramatically re-
uced, whereas diagnostic quality remained good (22). For
xample, by a combination of using a very stringent ECG
ose modulation program, reducing the tube voltage from
20 to 100 kV and reducing the tube current from 600 to
00 mAs to 350 to 450 mAs, the average effective dose was
educed from an estimated 28.4 to 5.1 mSv. This work
ighlights the importance of physicians paying careful
ttention to radiation dosimetry in CT and other X-ray
tudies and the dramatic dose reduction that can be achieved
ith current equipment and conscientious effort.
harmacologic stress. Rao et al. (23) performed a retro-
pective analysis of 252 patients undergoing vasodilator
PI, with ECG criteria that were positive for ischemia. Of
hese, 161 (65%) also showed ischemia on MPI. In a subset
f 106 patients, invasive angiography was performed; the
esults showed that the distribution of ischemic ECG
hanges during adenosine did not localize the ischemic
efect on SPECT MPI or territories of significant stenosis
n angiography. Because vasodilators have substantial side-
ffects, there is growing interest in selective adenosine A2a
eceptor antagonists, which might have less substantial
ide-effects. The safety of regadenoson in combination with
ubmaximal exercise was shown in a randomized trial
nvolving 60 patients (24), whereas Busse et al. (25) dem-
nstrated the safety of binodenoson in 84 asthmatic
atients.
V dyssynchrony. Although cardiac resynchronization
herapy is becoming more widely used in heart failure
atients, 30% of patients do not respond to treatment. It has
een suggested that cardiac dyssynchrony is important in
he response to cardiac resynchronization therapy. Various
bstracts focused on the application of Fourier phase anal-
sis to quantify LV dyssynchrony, with the phase SD and
istogram bandwidth. Trimble et al. (26) evaluated 125
eart failure patients and reported more extensive mechan-
cal dyssynchrony in ischemic cardiomyopathy as compared
ith nonischemic cardiomyopathy. As expected, heart fail-
re patients with a wider QRS complex (120 ms) also
xhibited more extensive dyssynchrony (27).
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ward symposium included 6 oral presentations that were
elected on the basis of their scientific merit and reviewer
cores. The symposium highlighted the quality and diversity
f current research in cardiovascular radionuclide and CT
maging. Saeed et al. (28) won the Young Investigator
ward, reporting on a multi-tracer PET study focusing on
yocardial blood flow and cardiac metabolism in obese and
iabetic patients. The authors demonstrated the impact of
ender on changes in myocardial substrate use in the
ransition from obesity and insulin resistance to overt
iabetes, by showing greater fatty acid use in obese and
iabetic women compared with men, and suggested that
his might partially be responsible for the higher mortality
n diabetic women versus men. Suzuki et al. (29) focused on
he utility of motion-frozen MPI SPECT in obese individ-
als. These images are obtained by nonlinear warping of
ated SPECT data to a static dataset, which improved the
ccuracy for detecting CAD in a group of 90 patients with
body mass index above 30 kg/m2. Lertsburapa et al. (30)
eported on the prognostic value of LV ejection fraction
btained from gated rubidium-82 PET perfusion imaging.
n 1,740 patients, LV ejection fraction provided incremental
rognostic value to perfusion data, emphasizing the clinical
mportance of this additional information. Al-Mallah et al.
31) analyzed a group of 7,718 patients undergoing MPI
PECT and stratified the patients according to the degree
f renal dysfunction; within each stage of renal function,
atients with an abnormal MPI had higher incidence of
eath and myocardial infarction. Patel et al. (32) compared
ated SPECT and magnetic resonance imaging for the
ssessment of LV function and volumes in 40 patients with
bnormal MPI. Good correlations between gated SPECT
nd magnetic resonance imaging for assessment of function
nd volumes were shown. The agreement for assessment of
egional wall thickening was somewhat less, but co-
egistration of the 2 technologies significantly improved the
greement. Hsu et al. (33) described experiments with
maging phantoms to define atherosclerotic plaques with
imultaneous dual-source/dual-energy X-ray CT. The au-
hors observed that calcium content within phantom lesions
an be accurately identified with this technique and specu-
ated that the method might be useful for more detailed
valuation of plaque constitution or vulnerability.
onclusions
n keeping with the theme of the ASNC 2007 Scientific
essions, “Imagine the Future,” the presentations and ab-
tracts presented at the meeting offer a vision of the future
f noninvasive cardiac imaging, including the use of multi-
odality hybrid imaging in the evaluation of patients with
eart disease. In addition, the meeting presented important
ew technologies and tracers that underscore the continuedmportance of nuclear imaging in the assessment of cardio-ascular disease. Next year’s meeting will be held in Boston
rom September 11 to 14.
eprint requests and correspondence: Dr. Raymond Russell III,
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